Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo

Journal: Nature Communications

Published: 2018-01-26

DOI: 10.1038/s41467-017-02762-z

Affiliations: 14

Authors: 18

Go to article
Institutions FC
Institute of Experimental and Clinical Pharmacology and Toxicology, Uni Freiburg, Germany 0.33
Department of Computer Science (IIF), Uni Freiburg, Germany 0.11
The Mindich Child Health and Development Institute (MCHDI), ISMMS, United States of America (USA) 0.07
TUM Department of Cardiovascular Surgery, Germany 0.07
TUM Institute for Translational Cardiac Surgery (INSURE), Germany 0.07
Division of Epigenomics and Cancer Risk Factors, DKFZ, Germany 0.06
Institut für Rechtsmedizin, LMU, Germany 0.06
Department of Obstetrics, Gynecology, and Reproductive Science, ISMMS, United States of America (USA) 0.06
Jena University Hospital (UKJ), FSU, Germany 0.06
Department of Cardiology and Angiology II, UHZ, Germany 0.03
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0.03
Munich Heart Alliance (MHA), Germany 0.02
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.02
Department of Pediatrics, ISMMS, United States of America (USA) 0.02